Clinical trial

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite…

NCT00490841 · Abbott Medical Devices, Industry · Completed

Key facts

NCT number NCT00490841
Title The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis
Official title A Clinical Trial to Assess the Safety and Efficacy of the RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Suboptimal Post-procedural Percutaneous Transluminal Angioplasty (PTA) in de Novo or Restenotic Renal Artery Stenoses in Patients With Uncontrolled Hypertension.
Acronym HERCULES
Lead sponsor Abbott Medical Devices, Industry
Status Completed
Study type Interventional
Conditions Renal Artery Obstruction, Hypertension, Renal
Intervention type Device
Interventions Herculink Elite Renal Stent System
Enrollment 202
Start date Aug 1, 2007
Primary completion Jun 1, 2010
Completion Dec 1, 2012
First posted Jun 25, 2007
Last update posted Dec 18, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies